1. Psychosocial Barriers and Facilitators to Clinical Trial Enrollment and Adherence for Adolescents With Cancer
- Author
-
Rebecca Block, Natasha Buchanan, Ashley Wilder Smith, and Eric Tai
- Subjects
Clinical Trials as Topic ,Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Adolescent ,Accrual ,business.industry ,Patient Selection ,Cancer ,medicine.disease ,Affect (psychology) ,Clinical trial ,Neoplasms ,Family medicine ,Pediatrics, Perinatology and Child Health ,Physical therapy ,medicine ,Humans ,Patient Compliance ,Psychology ,Supplement Article ,Patient compliance ,business ,Psychosocial - Abstract
Adolescents (aged 15–19 years) have not experienced the same survival gains as children and older adults diagnosed with cancer. Poor clinical trial enrollment and adherence rates among adolescents may account for some of this disparity. Although biological, regulatory, systemic, and practice-related challenges to clinical trial enrollment and adherence have been examined, studies of psychosocial factors, which can serve as barriers or facilitators to enrollment and adherence, are limited. To bring attention to these psychological factors, we reviewed existing literature on psychosocial barriers and facilitators that can affect an adolescent’s decision to enroll and adhere to a clinical trial. We also provide potential strategies to address psychosocial factors affecting clinical trial accrual and adherence.
- Published
- 2014
- Full Text
- View/download PDF